Belgium· BE-AMP-SAM092145-00

Maxitrol

A dexamethason mit antiinfektiva product containing polymyxin b sulfate, registered in Belgium by Novartis Pharma. The same ATC class is registered in 11 of our 19 countries.

ATC S01CA01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about polymyxin b sulfateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dexamethason mit antiinfektiva is registered in 11 of 19 countries.

Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search dexamethason mit antiinfektiva products by name

Dexamethason mit antiinfektiva · ATC S01CA01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Polymyxin B Sulfate
Manufacturer: Novartis Pharma
Country: Belgium (BE)
ATC code: S01CA01
ATC class: Dexamethason mit Antiinfektiva
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

1 priced

be_apb
0119198
EUR 8.22
be_apb
0711424

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexamethason mit antiinfektiva in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamethason mit antiinfektiva products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

Germany · Polymyxin B Sulfat Smartpractice Europe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/3e3dc25b-8ad5-4130-adf7-d83a55e0a1a7
GET /v1/drugs/3e3dc25b-8ad5-4130-adf7-d83a55e0a1a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye ointment",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Maxitrol",
  "name_fr": "Maxitrol",
  "name_nl": "Maxitrol",
  "amp_code": "SAM092145-00",
  "strengths": [
    "6000.0000",
    "1.0000",
    "1.0000",
    "3500.0000",
    "6000.0000",
    "1.0000",
    "0.5000",
    "0.1000",
    "30.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Polymyxin B Sulfate",
    "Dexamethasone",
    "Neomycin Sulfate",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Wool Fat"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dexamethasone and Antiinfectives",
  "authorisation_numbers": [
    "BE092145"
  ]
}

API reference MCP server Plans

See everything about dexamethason mit antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console